The purpose of this study is to determine the mumps virus strength at the end of shelf-life (expiration date) of an approved vaccine.
Name: Comparator: M-M-R(TM) II, measles, mumps, and rubella virus vaccine live
Description: 0.5 mL subcutaneous injection of one of three sub-lots on Day 0Type: BiologicalControl Group Mumps Expiry Group 1 Mumps Expiry Group 2
Name: Comparator: VARIVAX(TM) Varicella Virus Vaccine Live (Oka-Merck)
Description: 0.5 mL subcutaneous injection on Day 0Type: BiologicalControl Group Mumps Expiry Group 1 Mumps Expiry Group 2
Allocation: Randomized
Single Group Assignment
There is one SNP
A Study of An Approved Vaccine at Mumps Expiry Potency in Healthy Children 12 to 18 Months of Age (V205C-007)(COMPLETED) The purpose of this study is to determine the mumps virus strength at the end of shelf-life (expiration date) of an approved vaccine. --- V205C ---